INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD reported 1 transaction at LYELL IMMUNOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/19/2026ACC: 0001140361-26-025796
→
10% Owner
Since Jun 2026
-66.50K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
66.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−66.50K
Price / share
—
Trade value
—
% of position
2.2%
6/15/2026
3M→2.93M
Total
Net shares
−66.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | J · J | −66.50K | — | — | 2.2% | 3M | 2.93M |
| Total | −66.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported